337 related articles for article (PubMed ID: 34088288)
81. Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors.
Li W; Gupta SK; Han W; Kundson RA; Nelson S; Knutson D; Greipp PT; Elsawa SF; Sotomayor EM; Gupta M
J Hematol Oncol; 2019 Jul; 12(1):73. PubMed ID: 31288832
[TBL] [Abstract][Full Text] [Related]
82. Matrine induces apoptosis in angiotensin II-stimulated hyperplasia of cardiac fibroblasts: effects on Bcl-2/Bax expression and caspase-3 activation.
Li Y; Wang B; Zhou C; Bi Y
Basic Clin Pharmacol Toxicol; 2007 Jul; 101(1):1-8. PubMed ID: 17577309
[TBL] [Abstract][Full Text] [Related]
83. [In vitro study of BRD4 inhibitor GSK525762A against primary adult common B-cell acute lymphoblastic leukemia cells in vitro].
Ma S; Chen C; Zhu J; Li Y; Wang X; Song X; Cao J; Xu K
Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):563-9. PubMed ID: 26304078
[TBL] [Abstract][Full Text] [Related]
84. Novel matrine derivative MD-1 attenuates hepatic fibrosis by inhibiting EGFR activation of hepatic stellate cells.
Feng Y; Ying HY; Qu Y; Cai XB; Xu MY; Lu LG
Protein Cell; 2016 Sep; 7(9):662-72. PubMed ID: 27342773
[TBL] [Abstract][Full Text] [Related]
85. Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma.
Hashiguchi T; Bruss N; Best S; Lam V; Danilova O; Paiva CJ; Wolf J; Gilbert EW; Okada CY; Kaur P; Drew L; Cidado J; Hurlin P; Danilov AV
Mol Cancer Ther; 2019 Sep; 18(9):1520-1532. PubMed ID: 31243099
[TBL] [Abstract][Full Text] [Related]
86. Matrine Inhibits Neuroblastoma Cell Proliferation and Migration by Enhancing Tribbles 3 Expression.
Shen X; Huang J; Liu G; Zhang H; Zhang X; Kong X; Du L
Oncol Res; 2018 Aug; 26(7):1133-1142. PubMed ID: 29386091
[TBL] [Abstract][Full Text] [Related]
87. Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3.
Dai ZJ; Gao J; Ji ZZ; Wang XJ; Ren HT; Liu XX; Wu WY; Kang HF; Guan HT
J Ethnopharmacol; 2009 May; 123(1):91-6. PubMed ID: 19429345
[TBL] [Abstract][Full Text] [Related]
88. Matrine Suppresses Reactive Oxygen Species (ROS)-Mediated MKKs/p38-Induced Inflammation in Oxidized Low-Density Lipoprotein (ox-LDL)-Stimulated Macrophages.
Zhou J; Ma W; Wang X; Liu H; Miao Y; Wang J; Du P; Chen Y; Zhang Y; Liu Z
Med Sci Monit; 2019 Jun; 25():4130-4136. PubMed ID: 31156213
[TBL] [Abstract][Full Text] [Related]
89. Matrine suppresses AGE-induced HAEC injury by inhibiting ROS-mediated NRLP3 inflammasome activation.
Zhang Y; Yang X; Qiu C; Liu F; Liu P; Liu Z
Eur J Pharmacol; 2018 Mar; 822():207-211. PubMed ID: 29374549
[TBL] [Abstract][Full Text] [Related]
90. Matrine improved the function of heart failure in rats via inhibiting apoptosis and blocking β3‑adrenoreceptor/endothelial nitric oxide synthase pathway.
Yu J; Yang S; Wang X; Gan R
Mol Med Rep; 2014 Dec; 10(6):3199-204. PubMed ID: 25322941
[TBL] [Abstract][Full Text] [Related]
91. Matrine reduces the proliferation of A549 cells via the p53/p21/PCNA/eIF4E signaling pathway.
Lu Z; Xiao Y; Liu X; Zhang Z; Xiao F; Bi Y
Mol Med Rep; 2017 May; 15(5):2415-2422. PubMed ID: 28447756
[TBL] [Abstract][Full Text] [Related]
92. Matrine-induced autophagy regulated by p53 through AMP-activated protein kinase in human hepatoma cells.
Xie SB; He XX; Yao SK
Int J Oncol; 2015 Aug; 47(2):517-26. PubMed ID: 26034977
[TBL] [Abstract][Full Text] [Related]
93. [Matrine and anti-tumor drugs in inhibiting the growth of human lung cancer cell line].
Zhu MY; Jiang ZH; Lu YW; Guo Y; Gan JJ
Zhong Xi Yi Jie He Xue Bao; 2008 Feb; 6(2):163-5. PubMed ID: 18241651
[TBL] [Abstract][Full Text] [Related]
94. Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells.
Zhang J; Li Y; Chen X; Liu T; Chen Y; He W; Zhang Q; Liu S
Oncol Rep; 2011 Jul; 26(1):115-24. PubMed ID: 21519796
[TBL] [Abstract][Full Text] [Related]
95. Matrine suppresses KRAS-driven pancreatic cancer growth by inhibiting autophagy-mediated energy metabolism.
Cho YR; Lee JH; Kim JH; Lee SY; Yoo S; Jung MK; Kim SJ; Yoo HJ; Pack CG; Rho JK; Son J
Mol Oncol; 2018 Jun; 12(7):1203-1215. PubMed ID: 29791786
[TBL] [Abstract][Full Text] [Related]
96. A study on isolation of chemical constituents from Sophora flavescens Ait. and their anti-glioma effects.
Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z
Afr J Tradit Complement Altern Med; 2014; 11(1):156-60. PubMed ID: 24653570
[TBL] [Abstract][Full Text] [Related]
97. Matrine inhibits IL-1β-induced expression of matrix metalloproteinases by suppressing the activation of MAPK and NF-κB in human chondrocytes in vitro.
Lu S; Xiao X; Cheng M
Int J Clin Exp Pathol; 2015; 8(5):4764-72. PubMed ID: 26191166
[TBL] [Abstract][Full Text] [Related]
98. Geniposide inhibits proliferation and induces apoptosis of diffuse large B-cell lymphoma cells by inactivating the HCP5/miR-27b-3p/MET axis.
Hu L; Zhao J; Liu Y; Liu X; Lu Q; Zeng Z; Zhu L; Tong X; Xu Q
Int J Med Sci; 2020; 17(17):2735-2743. PubMed ID: 33162801
[TBL] [Abstract][Full Text] [Related]
99. Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling.
Wang HQ; Jin JJ; Wang J
Oncol Rep; 2015 May; 33(5):2561-6. PubMed ID: 25760455
[TBL] [Abstract][Full Text] [Related]
100. Matrine inhibits the activity of translation factor eIF4E through dephosphorylation of 4E-BP1 in gastric MKN45 cells.
Jiang T; Zhu Y; Luo C; Lu X; Zhang W; Qiu F; Huang J
Planta Med; 2007 Sep; 73(11):1176-81. PubMed ID: 17823871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
